Interactions médicamenteuses
Efgartigimod alfa + Galcanezumab
Gravité: Modérée
Efgartigimod alfa and Galcanezumab: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG from degradation. Galcanezumab is an IgG4 monoclonal antibody, so its levels could fall and its migraine-preventive effect could weaken. Clinical data for this specific combination are lacking.
Ce que signifie cette interaction, en termes simples
Efgartigimod alfa and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Efgartigimod alfa belongs to Miscellaneous; Galcanezumab belongs to Central Nervous System.
Pourquoi elle survient
FcRn blockade by efgartigimod increases catabolism of IgG-based antibodies such as galcanezumab.
Conduite à tenir
Monitor migraine control and consider a change in preventive therapy if efficacy declines. Time galcanezumab doses with awareness that efficacy may fall during efgartigimod treatment.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Efgartigimod alfa et Galcanezumab, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Galcanezumab
Autres interactions de Efgartigimod alfa
- Adalimumab + Efgartigimod alfa Modérée
- Ado-trastuzumab + Efgartigimod alfa Modérée
- Basiliximab + Efgartigimod alfa Modérée
- Bevacizumab + Efgartigimod alfa Modérée
- Brentuximab + Efgartigimod alfa Modérée
- Denosumab + Efgartigimod alfa Modérée
Questions fréquentes
Can I take Efgartigimod alfa with Galcanezumab?
MediHelp rates the interaction as moderate. Efgartigimod alfa and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally protects IgG from degradation. Galcanezumab is an IgG4 monoclonal antibody, so its levels could fall and its migraine-preventive effect could weaken. Clinical data for this specific combination are lacking.
How serious is the interaction between Efgartigimod alfa and Galcanezumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine control and consider a change in preventive therapy if efficacy declines. Time galcanezumab doses with awareness that efficacy may fall during efgartigimod treatment.
What other medicines interact with Galcanezumab?
MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod / hyaluronidase sc, Rozanolixizumab. The full list is on the Galcanezumab page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
